
TRIM developed and engineered the medical watch through multiple functional prototypes, refining its design and mechanics for production.
Our work on the watch’s integrated construction, sealing and material selection supported CardiacSense’s development toward regulatory clearance. CardiacSense received FDA 510(k) clearances in 2023 and 2024.
The watch was used in a remote-monitoring pilot at KBC Rijeka in Croatia as part of the European HealthChain project.